DCGO
DocGo Inc.
$0.6138
+8.25%
$56.0M
No data for this timeframe.
Vol
Market Cap$56.0M
Cap SizeMicro Cap
Analyst ConsensusBuy (67%)
Inst. Holders7 funds
Inst. Value$6.4M
Inst. Activity3 buys / 2 sells
SEC Reports4
Recent Activity
May 12, 2026
Insider
Bienstock Lee sold 15,644 shares
Chief Executive Officer @ $0.5900 ($9.2K)
May 11, 2026
SEC
DocGo reported Q1 2026 revenue of $75.6M, down 21.3% YoY from $96.0M due to the wind-down of migrant-related programs (z
8-K — Impact 5/10
May 11, 2026
earnings_calendar
DCGO Q1 2026 Earnings After Market Close — 2026-05-11
Apr 22, 2026
SEC
DocGo Inc. has filed a definitive proxy statement (DEFA14A) ahead of its 2026 Annual Meeting, which includes a proposal
DEFA14A — Impact 4/10
Apr 22, 2026
SEC
DocGo Inc. announced the departure of board member Dr. Stephen Klasko, effective after the 2026 Annual Meeting, and the
8-K — Impact 3/10
Mar 30, 2026
Insider
Bienstock Lee sold 18,811 shares
Chief Executive Officer @ $0.5700 ($10.7K)
Inst.
MORGAN STANLEY — TRIM
614,362 shares ($539.3K)
Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
565,535 shares ($496.4K)
Price Targets
$1.88
+205.5% upside
Strong Buy
Current $0.6138
Low $1.00
Median $1.75
High $3.00
4 analysts
$1.00
$3.00
Analyst Ratings
3Strong Buy
5Buy
4Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 25, 2026 | Canaccord Genuity | MAINTAIN | Hold → Hold |
| Mar 17, 2026 | Stifel | MAINTAIN | Buy → Buy |
| Mar 17, 2026 | Cantor Fitzgerald | REITERATE | Overweight → Overweight |
| Mar 17, 2026 | Needham | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.15 ▼ -1583.3% | $-0.18 — $-0.12 | 28% YoY | 2 |
| Next Q | $-0.02 ▼ -128.9% | $-0.04 — $0.00 | 93% YoY | 2 |
| Current FY | $-0.42 ▼ -440.0% | $-0.55 — $-0.30 | 76% YoY | 2 |
| Next FY | $0.19 ▼ -70.9% | $0.04 — $0.34 | 144% YoY | 2 |
Latest Reports
MIXED
8-K
5/10
DocGo reported Q1 2026 revenue of $75.6M, down 21.3% YoY from $96.0M due to the wind-down of migrant-related programs (z
May 11, 2026
NEUTRAL
DEFA14A
4/10
DocGo Inc. has filed a definitive proxy statement (DEFA14A) ahead of its 2026 Annual Meeting, which includes a proposal
Apr 22, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $4.5M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $674.6K | NEW |
| MORGAN STANLEY | $539.3K | TRIM |
| RENAISSANCE TECHNOLOGIES LLC | $496.4K | ADD |
| WELLS FARGO & COMPANY/MN | $88.5K | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 12, 2026 | Bienstock Lee | F | $9.2K |
| Mar 30, 2026 | Bienstock Lee | F | $10.7K |
7 institutional holders with $6.4M total value (7,233,719 shares) as of 2025-Q4. Top holders: VANGUARD, CHARLES, MORGAN. Net buying activity: 3 institutions added/increased vs 2 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 5,092,950 | $4.5M | 70.4% | — |
| 2 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 768,497 | $674.6K | 10.6% | NEW |
| 3 | MORGAN STANLEY | 614,362 | $539.3K | 8.5% | TRIM -36.1% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 565,535 | $496.4K | 7.8% | ADD +81.2% |
| 5 | WELLS FARGO & COMPANY/MN | 100,811 | $88.5K | 1.4% | ADD +44.3% |
| 6 | BANK OF AMERICA CORP /DE/ | 79,253 | $69.5K | 1.1% | TRIM -73.0% |
| 7 | FMR LLC | 12,311 | $10.8K | 0.2% | ADD +36.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 960,985 | 614,362 | -36.1% | $539.3K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 312,135 | 565,535 | +81.2% | $496.4K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 69,854 | 100,811 | +44.3% | $88.5K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 293,975 | 79,253 | -73.0% | $69.5K | 2025-Q4 |
| FMR LLC | ADD | 9,051 | 12,311 | +36.0% | $10.8K | 2025-Q4 |
| MORGAN STANLEY | TRIM | 1,528,109 | 960,985 | -37.1% | $1.3M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 11,339 | 0 | -100.0% | $0.00 | 2025-Q3 |
| MORGAN STANLEY | DOUBLED | 331,676 | 1,528,109 | +360.7% | $2.4M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 165,282 | 313,563 | +89.7% | $492.3K | 2025-Q2 |
| UBS Group AG | TRIM | 322,891 | 169,022 | -47.7% | $265.4K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | NEAR_EXIT | 88,104 | 11,339 | -87.1% | $17.8K | 2025-Q2 |
| FMR LLC | DOUBLED | 3,025 | 7,869 | +160.1% | $12.4K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 473,434 | 331,676 | -29.9% | $875.6K | 2025-Q1 |
| CITADEL ADVISORS LLC | ADD | 229,958 | 288,326 | +25.4% | $761.2K | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 173,700 | 88,104 | -49.3% | $232.6K | 2025-Q1 |
| FMR LLC | TRIM | 4,479 | 3,025 | -32.5% | $8.0K | 2025-Q1 |
| MORGAN STANLEY | ADD | 371,232 | 473,434 | +27.5% | $2.0M | 2024-Q4 |
| UBS Group AG | DOUBLED | 130,470 | 399,288 | +206.0% | $1.7M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 51,300 | 350,600 | +583.4% | $1.5M | 2024-Q4 |
| CITADEL ADVISORS LLC | DOUBLED | 16,782 | 229,958 | +1270.3% | $975.0K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 43,879 | 57,463 | +31.0% | $243.6K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 770,210 | — | $2.6M | 2024-Q3 |
| MORGAN STANLEY | DOUBLED | 176,063 | 371,232 | +110.9% | $1.2M | 2024-Q3 |
1 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 12, 2026 | Bienstock Lee | Chief Executive Officer | F | 15,644 | $0.5900 | $9.2K |
| Mar 30, 2026 | Bienstock Lee | Chief Executive Officer | F | 18,811 | $0.5700 | $10.7K |
4 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 1 mixed, 2 neutral. Avg impact: 4.5/10.
MIXED
8-K
5/10
DocGo reported Q1 2026 revenue of $75.6M, down 21.3% YoY from $96.0M due to the wind-down of migrant
May 11, 2026
NEUTRAL
DEFA14A
4/10
DocGo Inc. has filed a definitive proxy statement (DEFA14A) ahead of its 2026 Annual Meeting, which
Apr 22, 2026
NEUTRAL
8-K
3/10
DocGo Inc. announced the departure of board member Dr. Stephen Klasko, effective after the 2026 Annu
Apr 22, 2026
BULLISH
INST-CLUSTER
6/10
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and UBS — increased their
Feb 28, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (67% buy). Based on 12 analysts: 3 strong buy, 5 buy, 4 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$1.88 mean target
+205.5% upside
Strong Buy (2.40)
$1.00 Low
$3.00 High
| Metric | Value |
|---|---|
| Current Price | $0.6138 |
| Target Low | $1.00 |
| Target Mean | $1.88 |
| Target Median | $1.75 |
| Target High | $3.00 |
| # Analysts | 4 |
| Recommendation | Strong Buy (2.40) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.15 | $-0.18 | $-0.12 | 28.0% | -1583.3% | — | $0.1B | -6.2% | 2 |
| Next Q 2026-09-30 |
$-0.02 | $-0.04 | $0.00 | 93.4% | -128.9% | — | $0.1B | 7.7% | 2 |
| Current FY 2026-12-31 |
$-0.42 | $-0.55 | $-0.30 | 76.4% | -440.0% | 2↑ 0↓ | $0.3B | -4.9% | 2 |
| Next FY 2027-12-31 |
$0.19 | $0.04 | $0.34 | 144.0% | -70.9% | 1↑ 0↓ | $0.3B | 6.7% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.151 | |
| 7d ago | $-0.009 | -0.142 |
| 30d ago | $-0.009 | -0.142 |
| 60d ago | $-0.185 | +0.034 |
| 90d ago | $-0.185 | +0.034 |
4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 25, 2026 | Canaccord Genuity | MAINTAIN | Hold | Hold |
| Mar 17, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Mar 17, 2026 | Cantor Fitzgerald | REITERATE | Overweight | Overweight |
| Mar 17, 2026 | Needham | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 3 | 5 | 4 | 0 | 0 | 67% | |
| Apr 1, 2026 | 3 | 5 | 4 | 0 | 0 | 67% | |
| Mar 1, 2026 | 3 | 5 | 4 | 0 | 0 | 67% | |
| Feb 1, 2026 | 3 | 5 | 4 | 0 | 0 | 67% | |
| Jan 1, 2026 | 3 | 6 | 4 | 0 | 0 | 69% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 11, 2026
earnings_calendar
DCGO Q1 2026 Earnings After Market Close — 2026-05-11
Apr 13, 2026
short_volume
Short Volume: DCGO — 59.6% short (0.5M / 0.8M)
Short: 488,792 | Exempt: 88,920 | TRF Vol: 819,635 | Short Ratio: 59.6% | Off-exchange volume (dark pool + OTC)
Apr 10, 2026
short_volume
Short Volume: DCGO — 61.6% short (0.5M / 0.8M)
Short: 473,423 | Exempt: 23,057 | TRF Vol: 768,503 | Short Ratio: 61.6% | Off-exchange volume (dark pool + OTC)
Apr 1, 2026
short_volume
Short Volume: DCGO — 64.3% short (0.8M / 1.2M)
Short: 785,133 | Exempt: 68,238 | TRF Vol: 1,220,969 | Short Ratio: 64.3% | Off-exchange volume (dark pool + OTC)
Mar 25, 2026
short_volume
Short Volume: DCGO — 72.8% short (0.7M / 1.0M)
Short: 712,858 | Exempt: 1,100 | TRF Vol: 978,921 | Short Ratio: 72.8% | Off-exchange volume (dark pool + OTC)
Mar 23, 2026
short_volume
Short Volume: DCGO — 69.0% short (0.4M / 0.6M)
Short: 432,845 | Exempt: 0 | TRF Vol: 626,867 | Short Ratio: 69.0% | Off-exchange volume (dark pool + OTC)
Mar 16, 2026
earnings_calendar
DCGO Q4 2025 Earnings After Market Close — 2026-03-16